Paper39786607
Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.
Hrckulak D and 6 others. Transgenic Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells. Papers, record 39786607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39786607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Red Fluorescent Protein | Major topic |
| Luminescent Proteins | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Lung Neoplasms | |
| DNA Nucleotidyltransferases | |
| Mice, Transgenic | |
| Gene Knock-In Techniques |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| 20-31322S | Grantová Agentura České Republiky | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed | ||
| EXCELES, LX22NPO5102 | Ministerstvo Školství, Mládeže a Tělovýchovy | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 41030963 | Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KrasG12D oncogene-expressing tumor cells. | https://conductscience.org/library/papers/41030963 |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16299475 | A guide to choosing fluorescent proteins. | Nat Methods | 2005 | https://conductscience.org/library/papers/16299475 | PubMed |
| 2 | 15093544 | Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. | Cancer Cell | 2004 | https://conductscience.org/library/papers/15093544 | PubMed |
| 3 | 15121172 | Utilization of adenovirus vectors for multiple gene transfer applications. | Methods | 2004 | https://conductscience.org/library/papers/15121172 | PubMed |
| 4 | 21113151 | Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. | Nature | 2011 | https://conductscience.org/library/papers/21113151 | PubMed |
| 5 | 36216931 | Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor. | Nat Med | 2022 | https://conductscience.org/library/papers/36216931 | PubMed |
| 6 | 22810696 | Comprehensive molecular characterization of human colon and rectal cancer. | Nature | 2012 | https://conductscience.org/library/papers/22810696 | PubMed |
| 7 | 11751630 | Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. | Genes Dev | 2001 | https://conductscience.org/library/papers/11751630 | PubMed |
| 8 | 38319359 | Molecular pathological classification of colorectal cancer-an update. | Virchows Arch | 2024 | https://conductscience.org/library/papers/38319359 | PubMed |
| 9 | 10835623 | High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. | Nat Genet | 2000 | https://conductscience.org/library/papers/10835623 | PubMed |
| 10 | 21993244 | RAS oncogenes: weaving a tumorigenic web. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21993244 | PubMed |
| 11 | 26448360 | Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging. | Nat Protoc | 2015 | https://conductscience.org/library/papers/26448360 | PubMed |
| 12 | 25207767 | Pancreatic adenocarcinoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25207767 | PubMed |
| 13 | 27163859 | Cre Recombinase and Other Tyrosine Recombinases. | Chem Rev | 2016 | https://conductscience.org/library/papers/27163859 | PubMed |
| 14 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 15 | 25934696 | HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis. | Mol Cancer Res | 2015 | https://conductscience.org/library/papers/25934696 | PubMed |
| 16 | 38105263 | Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/38105263 | PubMed |
| 17 | 14570950 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. | JAMA | 2003 | https://conductscience.org/library/papers/14570950 | PubMed |
| 18 | 20023653 | A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. | Nat Neurosci | 2010 | https://conductscience.org/library/papers/20023653 | PubMed |
| 19 | 34919824 | Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/34919824 | PubMed |
| 20 | 19329995 | Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. | Nature | 2009 | https://conductscience.org/library/papers/19329995 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39786607
GET https://conductscience.org/api/papers/v1/39786607/references?page=2